Cefuroxime axetil

Product NDC: 67877-215
11-digit product format: 678770215
Labeler code: 67877
Product ID: 67877-215_7c9fa966-9491-40a8-a57b-6f60dbf7bb55
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefuroxime axetil
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Ascend Laboratories, LLC
Application: ANDA065496
Marketing category: ANDA
Marketing start: 2010-12-01
Substance: CEFUROXIME AXETIL
Active strength: 250 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065496-001	CEFUROXIME AXETIL	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB		2010-06-07
A065496-002	CEFUROXIME AXETIL	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB		2010-06-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065496-001	AB
A065496-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065496-001	CEFUROXIME AXETIL	EQ 250MG BASE	TABLET / ORAL	AB	2010-06-07	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065496-002	CEFUROXIME AXETIL	EQ 500MG BASE	TABLET / ORAL	AB	2010-06-07	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065496-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065496-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065496-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065496-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065496-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065496-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065496-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065496-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065496-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065496-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065496-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065496-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065496-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065496-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065496-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065496-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065496-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065496-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065496-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065496-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065496-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065496-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065496-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065496-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065496-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065496-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065496-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065496-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065496-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065496-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065496-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065496-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065496-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065496-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065496-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065496-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065496-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065496-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065496-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065496-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefuroxime axetil
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFUROXIME AXETIL	250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
Z49QDT0J8Z	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309097	Internal RxNorm lookup
309098	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
dd11e4b9-7730-4d3a-81ca-16f15de09759	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ba66f2a7-7ba5-e81a-8863-a38bd5c2e969	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
67877-215-01	Cefuroxime axetil	100 in 1 BOTTLE	TABLET, FILM COATED	100	25
67877-215-20	Cefuroxime axetil	20 in 1 BOTTLE	TABLET, FILM COATED	20	25
67877-215-60	Cefuroxime axetil	60 in 1 BOTTLE	TABLET, FILM COATED	60	25
67877-215-84	Cefuroxime axetil	10 in 1 BLISTER PACK	TABLET, FILM COATED	10	25
67877-215-84	Cefuroxime axetil	30 in 1 CARTON	TABLET, FILM COATED	30	25

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67877-215-20	EA - Each	67877-215	c93a9e1c-0609-443c-8c59-b1c2fd2e8c40	1	2012-07-24
67877-215-60	EA - Each	67877-215	9d640c6f-5bc2-481c-b7f2-65b4975954bc	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Cefuroxime axetil	ACTIVE INGREDIENT	Z49QDT0J8Z	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
Cefuroxime	ACTIVE MOIETY	O1R9FJ93ED	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	8
Cefuroxime axetil	ACTIVE INGREDIENT	Z49QDT0J8Z	CEFUROXIME AXETIL TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.]	2
Cefuroxime	ACTIVE MOIETY	O1R9FJ93ED	CEFUROXIME AXETIL TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67877-215	CEFUROXIME AXETIL TABLET, FILM COATED [ASCEND LABORATORIES, LLC]	24	Current NDC, Legacy NDC, 5 package rows	20230202_dd11e4b9-7730-4d3a-81ca-16f15de09759.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefuroxime axetil	CEFUROXIME AXETIL	Golden State Medical Supply, Inc.	bb7955fe-5111-1662-e053-2a95a90a85a1	2026-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	NuCare Pharmaceuticals, Inc.	4e4426a4-0ca9-dad5-e063-6294a90a5fdb	2026-03-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	Advanced Rx of Tennessee, LLC	48d96608-d3da-b512-e063-6294a90a07d5	2026-01-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	Redpharm Drug	3744f28c-c7e1-259c-e063-6294a90a10ed	2025-12-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	PD-Rx Pharmaceuticals, Inc.	2af8f061-c0e1-3a1c-e054-00144ff8d46c	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	PD-Rx Pharmaceuticals, Inc.	2af94304-8118-41c7-e054-00144ff8d46c	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	Ascend Laboratories, LLC	dd11e4b9-7730-4d3a-81ca-16f15de09759	2025-10-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496 ndc (product): 67877-215
Cefuroxime axetil	CEFUROXIME AXETIL	Major Pharmaceuticals	44e1fb4d-4b61-40da-9974-0bd2006eb828	2025-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	American Health Packaging	f38418a7-dd90-4f20-b747-7ac086c53015	2025-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	PD-Rx Pharmaceuticals, Inc.	15cabe73-f39d-4798-a840-115fe94f8f96	2025-03-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	A-S Medication Solutions	84593261-838c-433a-8d9d-1d37b11058da	2024-09-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	NuCare Pharmaceuticals,Inc.	83476d51-be74-748b-e053-2a91aa0a3d36	2024-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	NuCare Pharmaceuticals,Inc.	8c3c1c85-cbce-66e2-e053-2a95a90a94fe	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	A-S Medication Solutions	c89e8f4d-96c0-44c6-906a-b803141920b1	2024-02-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496
Cefuroxime axetil	CEFUROXIME AXETIL	Proficient Rx LP	e9a020ec-e446-469a-b1d1-07e82eefa305	2023-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065496 application number: ANDA065496

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
Z49QDT0J8Z	CEFUROXIME AXETIL	64544-07-6	CEFUROXIME AXETIL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	c89e8f4d-96c0-44c6-906a-b803141920b1	27
309098	cefuroxime axetil 500 MG Oral Tablet	PSN	c89e8f4d-96c0-44c6-906a-b803141920b1	27
309097	cefuroxime 250 MG Oral Tablet	SCD	c89e8f4d-96c0-44c6-906a-b803141920b1	27
309098	cefuroxime 500 MG Oral Tablet	SCD	c89e8f4d-96c0-44c6-906a-b803141920b1	27
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	c89e8f4d-96c0-44c6-906a-b803141920b1	27
309098	cefuroxime (as cefuroxime axetil) 500 MG Oral Tablet	SY	c89e8f4d-96c0-44c6-906a-b803141920b1	27
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	dd11e4b9-7730-4d3a-81ca-16f15de09759	25
309098	cefuroxime axetil 500 MG Oral Tablet	PSN	dd11e4b9-7730-4d3a-81ca-16f15de09759	25
309097	cefuroxime 250 MG Oral Tablet	SCD	dd11e4b9-7730-4d3a-81ca-16f15de09759	25
309098	cefuroxime 500 MG Oral Tablet	SCD	dd11e4b9-7730-4d3a-81ca-16f15de09759	25
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	dd11e4b9-7730-4d3a-81ca-16f15de09759	25
309098	cefuroxime (as cefuroxime axetil) 500 MG Oral Tablet	SY	dd11e4b9-7730-4d3a-81ca-16f15de09759	25
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	2af8f061-c0e1-3a1c-e054-00144ff8d46c	24
309097	cefuroxime 250 MG Oral Tablet	SCD	2af8f061-c0e1-3a1c-e054-00144ff8d46c	24
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	2af8f061-c0e1-3a1c-e054-00144ff8d46c	24
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	2af94304-8118-41c7-e054-00144ff8d46c	22
309097	cefuroxime 250 MG Oral Tablet	SCD	2af94304-8118-41c7-e054-00144ff8d46c	22
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	2af94304-8118-41c7-e054-00144ff8d46c	22
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	84593261-838c-433a-8d9d-1d37b11058da	17
309097	cefuroxime 250 MG Oral Tablet	SCD	84593261-838c-433a-8d9d-1d37b11058da	17
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	84593261-838c-433a-8d9d-1d37b11058da	17
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	e9a020ec-e446-469a-b1d1-07e82eefa305	5
309097	cefuroxime 250 MG Oral Tablet	SCD	e9a020ec-e446-469a-b1d1-07e82eefa305	5
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	e9a020ec-e446-469a-b1d1-07e82eefa305	5
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	b73bebbe-fd90-4e9b-864a-4906d8bab305	3
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	8c3c1c85-cbce-66e2-e053-2a95a90a94fe	3
309097	cefuroxime 250 MG Oral Tablet	SCD	b73bebbe-fd90-4e9b-864a-4906d8bab305	3
309097	cefuroxime 250 MG Oral Tablet	SCD	8c3c1c85-cbce-66e2-e053-2a95a90a94fe	3
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	b73bebbe-fd90-4e9b-864a-4906d8bab305	3
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	8c3c1c85-cbce-66e2-e053-2a95a90a94fe	3
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	90001905-36e4-b0e1-e053-2995a90a4d93	2
309097	cefuroxime axetil 250 MG Oral Tablet	PSN	1bc56a86-735c-4787-826a-9bb59027fa09	2
309097	cefuroxime 250 MG Oral Tablet	SCD	90001905-36e4-b0e1-e053-2995a90a4d93	2
309097	cefuroxime 250 MG Oral Tablet	SCD	1bc56a86-735c-4787-826a-9bb59027fa09	2
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	1bc56a86-735c-4787-826a-9bb59027fa09	2
309097	cefuroxime (as cefuroxime axetil) 250 MG Oral Tablet	SY	90001905-36e4-b0e1-e053-2995a90a4d93	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
67877-215-01	67877021501	100 TABLET, FILM COATED in 1 BOTTLE (67877-215-01)		2010-12-01	0000-00-00	No	No	Current
67877-215-20	67877021520	20 TABLET, FILM COATED in 1 BOTTLE (67877-215-20)		2010-12-01	0000-00-00	No	No	Current
67877-215-60	67877021560	60 TABLET, FILM COATED in 1 BOTTLE (67877-215-60)		2010-12-01	0000-00-00	No	No	Current
67877-215-84	67877021584	30 BLISTER PACK in 1 CARTON (67877-215-84) / 10 TABLET, FILM COATED in 1 BLISTER PACK	30 blister pack	2010-12-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefuroxime axetil	PD-Rx Pharmaceuticals, Inc.	2025-10-15	HUMAN PRESCRIPTION DRUG LABEL	24
Cefuroxime axetil	PD-Rx Pharmaceuticals, Inc.	2025-10-15	HUMAN PRESCRIPTION DRUG LABEL	22
Cefuroxime axetil	Ascend Laboratories, LLC \| Alkem Laboratories Limited	2025-10-03	Human Prescription Drug Label	25
Cefuroxime axetil	A-S Medication Solutions	2024-09-11	Human Prescription Drug Label	17
Cefuroxime axetil	NuCare Pharmaceuticals,Inc.	2024-06-18	HUMAN PRESCRIPTION DRUG LABEL	3
Cefuroxime axetil	A-S Medication Solutions	2024-02-13	Human Prescription Drug Label	27
Cefuroxime axetil	Proficient Rx LP	2023-07-01	HUMAN PRESCRIPTION DRUG LABEL	5
Cefuroxime axetil	RPK Pharmaceuticals, Inc.	2023-06-07	Human Prescription Drug Label	3
Cefuroxime axetil	Bryant Ranch Prepack	2023-03-16	HUMAN PRESCRIPTION DRUG LABEL	101
Cefuroxime axetil	Bryant Ranch Prepack	2023-03-16	HUMAN PRESCRIPTION DRUG LABEL	101
CEFUROXIME AXETIL	Direct_Rx	2023-01-12	HUMAN PRESCRIPTION DRUG LABEL	2
Cefuroxime - H.J. Harkins Company, Inc. \| Ascend Laboratories, LLC \| Alkem Laboratories Limited, Daman	H.J. Harkins Company, Inc. \| Ascend Laboratories, LLC \| Alkem Laboratories Limited, Daman	2011-12-22	Human Prescription Drug Label	2